19 related articles for article (PubMed ID: 8432781)
1. Mutation analysis of the muscarinic cholinergic receptor genes in isolated growth hormone deficiency type IB.
Mohamadi A; Martari M; Holladay CD; Phillips JA; Mullis PE; Salvatori R
J Clin Endocrinol Metab; 2009 Jul; 94(7):2565-70. PubMed ID: 19417035
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanisms of growth hormone secretion are sexually dimorphic.
Jaffe CA; Ocampo-Lim B; Guo W; Krueger K; Sugahara I; DeMott-Friberg R; Bermann M; Barkan AL
J Clin Invest; 1998 Jul; 102(1):153-64. PubMed ID: 9649569
[TBL] [Abstract][Full Text] [Related]
3. Fibromyalgia syndrome: a pain modulation disorder related to altered limbic function?
Goldstein JA
Baillieres Clin Rheumatol; 1994 Nov; 8(4):777-800. PubMed ID: 7850880
[No Abstract] [Full Text] [Related]
4. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
5. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
6. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
7. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
Peñalva A; Muruais C; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
[TBL] [Abstract][Full Text] [Related]
8. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Barini A
J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
[TBL] [Abstract][Full Text] [Related]
9. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
[TBL] [Abstract][Full Text] [Related]
10. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
Müller EE; Locatelli V; Ghigo E; Cella SG; Loche S; Pintor C; Camanni F
Drugs; 1991 Feb; 41(2):161-77. PubMed ID: 1709847
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]